Travere Therapeutics, Inc. (TVTX)
51.63
+2.03
(+4.09%)
USD |
NASDAQ |
Nov 09, 16:00
50.99
-0.64
(-1.24%)
Pre-Market: 09:21
Travere Therapeutics Cash and Short Term Investments (Quarterly) : 471.82M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 471.82M |
| June 30, 2026 | 489.18M |
| March 31, 2026 | 264.68M |
| December 31, 2025 | 322.80M |
| September 30, 2025 | 254.53M |
| June 30, 2025 | 319.54M |
| March 31, 2025 | 322.24M |
| December 31, 2024 | 370.70M |
| September 30, 2024 | 277.44M |
| June 30, 2024 | 325.40M |
| March 31, 2024 | 441.04M |
| December 31, 2023 | 566.85M |
| September 30, 2023 | 634.64M |
| June 30, 2023 | 491.34M |
| March 31, 2023 | 561.51M |
| December 31, 2022 | 450.24M |
| September 30, 2022 | 506.33M |
| June 30, 2022 | 553.17M |
| March 31, 2022 | 603.39M |
| December 31, 2021 | 552.88M |
| September 30, 2021 | 551.18M |
| June 30, 2021 | 522.79M |
| March 31, 2021 | 520.87M |
| December 31, 2020 | 361.59M |
| September 30, 2020 | 456.27M |
| Date | Value |
|---|---|
| June 30, 2020 | 457.38M |
| March 31, 2020 | 356.46M |
| December 31, 2019 | 398.52M |
| September 30, 2019 | 407.02M |
| June 30, 2019 | 425.90M |
| March 31, 2019 | 447.65M |
| December 31, 2018 | 471.54M |
| September 30, 2018 | 478.81M |
| June 30, 2018 | 255.69M |
| March 31, 2018 | 264.06M |
| December 31, 2017 | 300.63M |
| September 30, 2017 | 303.87M |
| June 30, 2017 | 295.98M |
| March 31, 2017 | 248.16M |
| December 31, 2016 | 255.87M |
| September 30, 2016 | 274.30M |
| June 30, 2016 | 221.51M |
| March 31, 2016 | 222.34M |
| December 31, 2015 | 229.60M |
| September 30, 2015 | 235.28M |
| June 30, 2015 | 133.61M |
| March 31, 2015 | 126.33M |
| December 31, 2014 | 27.76M |
| September 30, 2014 | 37.79M |
| June 30, 2014 | 43.44M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.313B |
| TG Therapeutics, Inc. | 556.71M |
| Viridian Therapeutics, Inc. | 956.51M |
| BioMarin Pharmaceutical, Inc. | 736.01M |
| Emergent BioSolutions, Inc. | 176.90M |